Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F FROMM

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
Functional characterization of the human organic cation transporter 2 variant p.270Ala>SerOliver Zolk, Thomas F Solbach, Jörg König, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 13, 2008
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)Oliver Zolk, Thomas F Solbach, Jörg König, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 5, 2002
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoproteinC Pauli-Magnus, S Rekersbrink, U Klotz, et al.
British Journal of Clinical Pharmacology|June 22, 2021
The CredibleMeds<sup>®</sup> list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing informationMelanie I Then, Wahram Andrikyan, Renke Maas, et al.
Clinical Pharmacology and Therapeutics|July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPCMichael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.
European Journal of Clinical Pharmacology|October 24, 2012
Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristicsMartin F Fromm, Renke Maas, Thomas Tümena, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoproteinIouri Bachmakov, Sabine Rekersbrink, Ute Hofmann, et al.
Clinical Pharmacology and Therapeutics|April 24, 2024
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor TherapyLisa Cuba, Pauline Dürr, Frank Dörje, et al.
British Journal of Pharmacology|September 20, 2011
Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cellsC Fahrmayr, J König, D Auge, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2011
Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transportJuergen Kindla, Fabian Müller, Maren Mieth, et al.
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2009
Functional characterization of the human organic cation transporter 2 variant p.270Ala>SerOliver Zolk, Thomas F Solbach, Jörg König, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 13, 2008
Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)Oliver Zolk, Thomas F Solbach, Jörg König, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 5, 2002
Interaction of omeprazole, lansoprazole and pantoprazole with P-glycoproteinC Pauli-Magnus, S Rekersbrink, U Klotz, et al.
British Journal of Clinical Pharmacology|June 22, 2021
The CredibleMeds<sup>®</sup> list: Usage of QT interval prolonging drugs in Germany and discordances with prescribing informationMelanie I Then, Wahram Andrikyan, Renke Maas, et al.
Clinical Pharmacology and Therapeutics|July 11, 2024
Pseudo-Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPCMichael I Sponfeldner, Wahram Andrikyan, Renke Maas, et al.
European Journal of Clinical Pharmacology|October 24, 2012
Potentially inappropriate medications in a large cohort of patients in geriatric units: association with clinical and functional characteristicsMartin F Fromm, Renke Maas, Thomas Tümena, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 19, 2005
Characterisation of (R/S)-propafenone and its metabolites as substrates and inhibitors of P-glycoproteinIouri Bachmakov, Sabine Rekersbrink, Ute Hofmann, et al.
Clinical Pharmacology and Therapeutics|April 24, 2024
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor TherapyLisa Cuba, Pauline Dürr, Frank Dörje, et al.
British Journal of Pharmacology|September 20, 2011
Identification of drugs and drug metabolites as substrates of multidrug resistance protein 2 (MRP2) using triple-transfected MDCK-OATP1B1-UGT1A1-MRP2 cellsC Fahrmayr, J König, D Auge, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2011
Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transportJuergen Kindla, Fabian Müller, Maren Mieth, et al.
Pageof 25